Kaliumchlorid-Lösung Serag-Wiessner

Potassium chloride, the active ingredient in Kaliumchlorid-Lösung Serag-Wiessner, is an electrolyte presented as an intravenous solution for intravenous use. It supplies potassium ions to restore normal serum potassium levels and correct hypokalemia, supporting cardiac and muscular function in patients requiring potassium replacement therapy.

GNH USA supplies Kaliumchlorid-Lösung Serag-Wiessner as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide under strict quality standards, ensuring reliable availability and regulatory compliance for critical care settings.

Potassium chloride is used to treat electrolyte disturbances, particularly hypokalemia.

- Hypokalemia: restores serum potassium to normal levels, preventing cardiac arrhythmias. - Potassium replacement therapy: provides controlled potassium infusion during peri‑operative or critical‑care management. - Electrolyte imbalance: corrects low potassium contributing to muscle weakness and metabolic disturbances.

Potassium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Nausea: transient feeling of queasiness. - Vomiting: occasional emesis following infusion. - Transient hyperkalemia: temporary elevation of serum potassium if administered too rapidly. - Muscle weakness: temporary reduction in muscle strength. - Headache: mild headache during infusion.

Serious or Rare Side Effects: - Severe hyperkalemia: potentially life‑threatening cardiac arrhythmias. - Allergic reaction: rash, itching, or anaphylaxis. - Phlebitis: inflammation of the vein at the infusion site. - Cardiac arrest: rare but possible with extreme hyperkalemia. - Metabolic acidosis: rare disturbance in acid‑base balance.

When using potassium chloride intravenous solution, several precautions should be observed to ensure patient safety. - Assess serum potassium: verify baseline levels before infusion. - Infusion rate: administer slowly as recommended to avoid rapid rise. - Cardiac monitoring: continuous ECG monitoring for patients at risk of arrhythmia. - Renal function: evaluate kidney function as impaired excretion can increase risk. - Concomitant drugs: review use of ACE inhibitors, ARBs, or potassium‑sparing diuretics. - Store at ambient temperature: keep in original container, protect from light and moisture.

Potassium chloride can interact with several medications, affecting potassium balance or cardiac safety.

Major Interactions (Avoid): - ACE inhibitors, ARBs, or potassium‑sparing diuretics: may cause dangerous hyperkalemia. - Amiodarone: increases risk of severe hyperkalemia and cardiac arrhythmias. - Succinylcholine: can raise serum potassium levels markedly.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce renal potassium excretion. - Beta‑blockers: can potentiate hyperkalemia, especially in renal impairment. - Digoxin: heightened risk of cardiac toxicity when potassium levels are abnormal.